• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢曲松治疗对预防长期乙醇依赖P大鼠复发样饮酒行为的有效性。

Effectiveness of Ceftriaxone Treatment in Preventing Relapse-like Drinking Behavior Following Long-term Ethanol Dependence in P Rats.

作者信息

Rao Pss, Sari Y

机构信息

Department of Pharmacology, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH, USA.

出版信息

J Addict Res Ther. 2014;5. doi: 10.4172/2155-6105.1000183.

DOI:10.4172/2155-6105.1000183
PMID:25685609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4326063/
Abstract

OBJECTIVE

To evaluate the effectiveness of ceftriaxone treatment in attenuating relapse-like ethanol drinking behavior in male P rats following 14-weeks of continuous ethanol consumption.

METHODS

After 14-weeks of continuous access to free choice of 15% and 30% ethanol, male P rats were deprived of ethanol for two weeks. On the last five days of abstinence period, P rats were treated, once a day, with either saline or ceftriaxone (50 or 200 mg/kg; i.p.). This was followed by re-exposure to ethanol for the next 10 days to simulate the relapse-like ethanol drinking behavior.

RESULTS

Ceftriaxone treatment (during abstinence) reduced ethanol intake upon re-exposure to ethanol, compared to the saline treated P rats. This statistically significant reduction in ethanol consumption in P rats following treatment with ceftriaxone (200 mg/kg/day) was observed from Day 2 to Day 9. Similarly, water consumption in P rats treated with ceftriaxone was significantly higher than the saline treated group between Day 2 and Day 7. Importantly, ceftriaxone treatment at both doses did not cause any significant changes in body weight compared to saline treated group.

CONCLUSIONS

We report here that ceftriaxone at higher dose has been found to be effective in the attenuation of relapse-like ethanol-drinking behavior in chronic ethanol intake model. This is in accordance with previous data from our lab in cocaine animal model demonstrating that only higher dose of ceftriaxone has been effective in attenuating cocaine relapse.

摘要

目的

评估头孢曲松治疗对连续摄入乙醇14周的雄性P大鼠复发性乙醇饮用行为的缓解效果。

方法

在连续14周自由选择15%和30%乙醇后,雄性P大鼠被剥夺乙醇两周。在禁欲期的最后五天,P大鼠每天接受一次生理盐水或头孢曲松(50或200mg/kg;腹腔注射)治疗。随后在接下来的10天内再次接触乙醇,以模拟复发性乙醇饮用行为。

结果

与生理盐水处理的P大鼠相比,头孢曲松治疗(禁欲期间)在再次接触乙醇时减少了乙醇摄入量。在用头孢曲松(200mg/kg/天)治疗后的P大鼠中,从第2天到第9天观察到乙醇消耗的这种统计学显著减少。同样,在第2天到第7天之间,用头孢曲松治疗的P大鼠的水消耗量明显高于生理盐水处理组。重要的是,与生理盐水处理组相比,两种剂量的头孢曲松治疗均未引起体重的任何显著变化。

结论

我们在此报告,已发现高剂量的头孢曲松在慢性乙醇摄入模型中对缓解复发性乙醇饮用行为有效。这与我们实验室先前在可卡因动物模型中的数据一致,该数据表明只有高剂量的头孢曲松在减轻可卡因复发方面有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/4326063/a561d9063a3c/nihms637239f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/4326063/d36fc8e6e270/nihms637239f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/4326063/8f67c20cd65e/nihms637239f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/4326063/a561d9063a3c/nihms637239f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/4326063/d36fc8e6e270/nihms637239f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/4326063/8f67c20cd65e/nihms637239f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/4326063/a561d9063a3c/nihms637239f3.jpg

相似文献

1
Effectiveness of Ceftriaxone Treatment in Preventing Relapse-like Drinking Behavior Following Long-term Ethanol Dependence in P Rats.头孢曲松治疗对预防长期乙醇依赖P大鼠复发样饮酒行为的有效性。
J Addict Res Ther. 2014;5. doi: 10.4172/2155-6105.1000183.
2
Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats.头孢曲松,一种β-内酰胺类抗生素,可减轻酒精偏好大鼠的类似复发的饮酒行为。
J Psychopharmacol. 2013 Jun;27(6):541-9. doi: 10.1177/0269881113482529. Epub 2013 Mar 21.
3
Effects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats.头孢曲松对乙醇摄入的影响:xCT 和 GLT-1 同工型对 P 大鼠谷氨酸水平调节的可能作用。
Psychopharmacology (Berl). 2014 Oct;231(20):4049-57. doi: 10.1007/s00213-014-3545-y. Epub 2014 Apr 1.
4
Effects of ceftriaxone on chronic ethanol consumption: a potential role for xCT and GLT1 modulation of glutamate levels in male P rats.头孢曲松对慢性乙醇摄入的影响:xCT 和 GLT1 对雄性 P 大鼠谷氨酸水平调节的潜在作用。
J Mol Neurosci. 2014 Sep;54(1):71-7. doi: 10.1007/s12031-014-0251-5. Epub 2014 Feb 18.
5
Role of suppressing GLT-1 and xCT in ceftriaxone-induced attenuation of relapse-like alcohol drinking in alcohol-preferring rats.抑制 GLT-1 和 xCT 在头孢曲松诱导酒精偏好大鼠复饮样行为中的作用。
Addict Biol. 2022 Jul;27(4):e13178. doi: 10.1111/adb.13178.
6
Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats.头孢曲松,一种β-内酰胺类抗生素,可减少酒精偏爱大鼠的乙醇摄入量。
Alcohol Alcohol. 2011 May-Jun;46(3):239-46. doi: 10.1093/alcalc/agr023. Epub 2011 Mar 19.
7
Effects of (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline on glutamate transporter 1 and cysteine/glutamate exchanger as well as ethanol drinking behavior in male, alcohol-preferring rats.(R)-(-)-5-甲基-1-烟酰基-2-吡唑啉对雄性嗜酒大鼠谷氨酸转运体1和半胱氨酸/谷氨酸交换体以及乙醇饮用行为的影响
J Neurosci Res. 2015 Jun;93(6):930-7. doi: 10.1002/jnr.23554. Epub 2015 Jan 19.
8
Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in mu-opioid receptor density.禁欲后小鹿斑鼠的乙醇消耗:纳曲酮的作用及μ-阿片受体密度的变化
Alcohol Clin Exp Res. 1999 Jun;23(6):1008-14.
9
Acute and long term effects of buspirone treatments on voluntary ethanol intake in a rat model of alcoholism.丁螺环酮治疗对酒精中毒大鼠模型中乙醇自愿摄入量的急性和长期影响。
Alcohol Clin Exp Res. 1999 May;23(5):822-7.
10
Effects of ceftriaxone on the acquisition and maintenance of ethanol drinking in peri-adolescent and adult female alcohol-preferring (P) rats.头孢曲松对青春期前和成年雌性酒精偏好(P)大鼠饮酒获得和维持的影响。
Neuroscience. 2013 Jun 25;241:229-38. doi: 10.1016/j.neuroscience.2013.03.016. Epub 2013 Mar 26.

引用本文的文献

1
Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation.头孢曲松作为治疗高谷氨酸能状态的新型治疗药物:弥合临床前研究结果与临床转化之间的差距
Front Neurosci. 2022 Jul 5;16:841036. doi: 10.3389/fnins.2022.841036. eCollection 2022.
2
Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight.肠道微生物组对物质使用障碍的调节作用的证据:显而易见却被忽视。
Pharmacol Rev. 2021 Apr;73(2):571-596. doi: 10.1124/pharmrev.120.000144.
3
Influence of n-acetylcysteine maintenance on the pharmacodynamic effects of oral ethanol.

本文引用的文献

1
Effects of ceftriaxone on chronic ethanol consumption: a potential role for xCT and GLT1 modulation of glutamate levels in male P rats.头孢曲松对慢性乙醇摄入的影响:xCT 和 GLT1 对雄性 P 大鼠谷氨酸水平调节的潜在作用。
J Mol Neurosci. 2014 Sep;54(1):71-7. doi: 10.1007/s12031-014-0251-5. Epub 2014 Feb 18.
2
Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2.头孢曲松诱导谷氨酸转运体EAAT2上调减轻乙醇戒断反应
Neuropsychopharmacology. 2014 Jun;39(7):1674-84. doi: 10.1038/npp.2014.14. Epub 2014 Jan 23.
3
Chronic administration of the methylxanthine propentofylline impairs reinstatement to cocaine by a GLT-1-dependent mechanism.
N-乙酰半胱氨酸维持治疗对口服乙醇药效学的影响。
Pharmacol Biochem Behav. 2020 Nov;198:173037. doi: 10.1016/j.pbb.2020.173037. Epub 2020 Sep 4.
4
Potential of Glial Cell Modulators in the Management of Substance Use Disorders.神经胶质细胞调制物在物质使用障碍治疗中的潜力。
CNS Drugs. 2020 Jul;34(7):697-722. doi: 10.1007/s40263-020-00721-9.
5
Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review.β-内酰胺抗生素头孢曲松用于神经疾病的新用途:综述
Front Neurosci. 2019 Mar 26;13:236. doi: 10.3389/fnins.2019.00236. eCollection 2019.
6
Glial and neuroinflammatory targets for treating substance use disorders.用于治疗物质使用障碍的神经胶质和神经炎症靶点。
Drug Alcohol Depend. 2017 Nov 1;180:156-170. doi: 10.1016/j.drugalcdep.2017.08.003. Epub 2017 Aug 31.
7
Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug Abuse.谷氨酸转运:治疗药物滥用的新的基础到临床机制。
Int J Neuropsychopharmacol. 2017 Oct 1;20(10):797-812. doi: 10.1093/ijnp/pyx050.
8
Rat animal models for screening medications to treat alcohol use disorders.用于筛选治疗酒精使用障碍药物的大鼠动物模型。
Neuropharmacology. 2017 Aug 1;122:201-243. doi: 10.1016/j.neuropharm.2017.02.004. Epub 2017 Feb 16.
9
The neuroimmune transcriptome and alcohol dependence: potential for targeted therapies.神经免疫转录组与酒精依赖:靶向治疗的潜力
Pharmacogenomics. 2016 Dec;17(18):2081-2096. doi: 10.2217/pgs-2016-0062. Epub 2016 Dec 5.
10
Development and evaluation of a calcium alginate based oral ceftriaxone sodium formulation.基于海藻酸钙的口服头孢曲松钠制剂的研制与评价
Prog Biomater. 2016;5:117-133. doi: 10.1007/s40204-016-0051-9. Epub 2016 Jul 20.
慢性给予甲基黄嘌呤丙戊茶碱通过 GLT-1 依赖机制损害可卡因复吸。
Neuropsychopharmacology. 2014 Jan;39(2):499-506. doi: 10.1038/npp.2013.223. Epub 2013 Aug 29.
4
Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcohol-preferring rats.头孢曲松治疗影响酒精偏好大鼠 GLT1 和 ENT1 的水平以及乙醇摄入量。
J Mol Neurosci. 2013 Nov;51(3):779-87. doi: 10.1007/s12031-013-0064-y. Epub 2013 Jul 27.
5
Alcohol craving as a predictor of relapse.酒精渴求作为复吸的预测指标。
Am J Addict. 2012 Nov;21 Suppl 1:S20-6. doi: 10.1111/j.1521-0391.2012.00297.x.
6
Role of the major glutamate transporter GLT1 in nucleus accumbens core versus shell in cue-induced cocaine-seeking behavior.主要谷氨酸转运体 GLT1 在伏隔核核心与壳部在线索诱导可卡因寻求行为中的作用。
J Neurosci. 2013 May 29;33(22):9319-27. doi: 10.1523/JNEUROSCI.3278-12.2013.
7
Disrupted ventromedial prefrontal function, alcohol craving, and subsequent relapse risk.腹内侧前额叶功能紊乱、酒精渴求与随后的复发风险。
JAMA Psychiatry. 2013 Jul;70(7):727-39. doi: 10.1001/jamapsychiatry.2013.762.
8
Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats.头孢曲松,一种β-内酰胺类抗生素,可减轻酒精偏好大鼠的类似复发的饮酒行为。
J Psychopharmacol. 2013 Jun;27(6):541-9. doi: 10.1177/0269881113482529. Epub 2013 Mar 21.
9
Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter, GLT-1, reduces regional gliosis, and reduces post-traumatic seizures in the rat.颅脑损伤后使用头孢曲松治疗可恢复谷氨酸转运体 GLT-1 的表达,减少区域性神经胶质增生,并减少大鼠的外伤性癫痫发作。
J Neurotrauma. 2013 Aug 15;30(16):1434-41. doi: 10.1089/neu.2012.2712. Epub 2013 Jul 25.
10
Neuroimmunophilin GPI-1046 reduces ethanol consumption in part through activation of GLT1 in alcohol-preferring rats.神经免疫调节蛋白 GPI-1046 通过激活酒精偏好大鼠中的 GLT1 减少乙醇摄入量。
Neuroscience. 2012 Dec 27;227:327-35. doi: 10.1016/j.neuroscience.2012.10.007. Epub 2012 Oct 8.